These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 6184781
21. Natural coagulation inhibitors: an assessment in patients. Losito R, Gattiker H, Bilodeau G, Longpré B. Ann N Y Acad Sci; 1981; 370():714-9. PubMed ID: 6168229 [No Abstract] [Full Text] [Related]
22. Neutralization of human extrinsic (tissue-type) plasminogen activator in human plasma: no evidence for a specific inhibitor. Korninger C, Collen D. Thromb Haemost; 1981 Oct; 46(3):662-5. PubMed ID: 6171907 [Abstract] [Full Text] [Related]
23. Blood levels of proteinase inhibitors in pregnancy. Walker JE, Campbell DM, Ogston D. Br J Obstet Gynaecol; 1982 Mar; 89(3):208-10. PubMed ID: 6175337 [Abstract] [Full Text] [Related]
24. Proteases and protease inhibitors in cerulein-induced acute pancreatitis in rats. Kruse P, Lasson A, Hage E. J Surg Res; 1999 Aug; 85(2):294-300. PubMed ID: 10423332 [Abstract] [Full Text] [Related]
25. The fibrinolytic system in man. Reiner AP, Bell WR. Crit Rev Oncol Hematol; 1984 Aug; 2(1):33-81. PubMed ID: 6085039 [Abstract] [Full Text] [Related]
28. Inhibition of human factor Xa by various plasma protease inhibitors. Ellis V, Scully M, MacGregor I, Kakkar V. Biochim Biophys Acta; 1982 Feb 04; 701(1):24-31. PubMed ID: 6173074 [Abstract] [Full Text] [Related]
29. Inhibition of the human tissue plasminogen activator in plasma from different species. Häggroth L, Mattsson C, Friberg J. Thromb Res; 1984 Mar 15; 33(6):583-94. PubMed ID: 6202022 [Abstract] [Full Text] [Related]
31. Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragment. Schapira M, Ramus MA, Waeber B, Brunner HR, Jallat S, Carvallo D, Roitsch C, Courtney M. J Clin Invest; 1987 Aug 15; 80(2):582-5. PubMed ID: 3497179 [Abstract] [Full Text] [Related]
32. High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitors. Schapira M, Scott CF, James A, Silver LD, Kueppers F, James HL, Colman RW. Biochemistry; 1982 Feb 02; 21(3):567-72. PubMed ID: 6175341 [No Abstract] [Full Text] [Related]
33. Inhibitors of coagulation-fibrinolysis system and platelet function in patients with vertigo. Noda Y, Nakamura M, Sasaki M, Kosugi T. Auris Nasus Larynx; 1986 Feb 02; 13 Suppl 1():S75-9. PubMed ID: 2429647 [Abstract] [Full Text] [Related]
34. Natural proteinase inhibitors: blood coagulation inhibition and evolutionary relationships. Bikfalvi A, Beress L. Comp Biochem Physiol B; 1987 Feb 02; 87(3):435-41. PubMed ID: 2441925 [Abstract] [Full Text] [Related]
36. Oxidative inactivation of purified human alpha-2-antiplasmin, antithrombin III, and C1-inhibitor. Stief TW, Aab A, Heimburger N. Thromb Res; 1988 Mar 15; 49(6):581-9. PubMed ID: 2455361 [Abstract] [Full Text] [Related]
38. Purification of a plasminogen activator inhibitor indistinguishable from alpha1-antitrypsin and an urokinase inhibitor in pregnancy plasma. Clemmensen I, Thorsen S, Müllertz S. Haemostasis; 1976 Mar 15; 5(4):218-30. PubMed ID: 826461 [Abstract] [Full Text] [Related]